FIFTH THIRD BANCORP Underwriting AgreementUnderwriting Agreement • July 30th, 2020 • Fifth Third Bancorp • State commercial banks • New York
Contract Type FiledJuly 30th, 2020 Company Industry JurisdictionFifth Third Bancorp, an Ohio corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), 350,000 depositary shares (the “Securities” or the “Depositary Shares”), each representing 1/25th of a share of the Company’s Series L Preferred Stock, no par value per share and liquidation preference of $25,000 per share (each, an “Underlying
EXECUTION VERSION UNDERWRITING AGREEMENT MEDTRONIC, INC. Floating Rate Senior Notes due 2017 Underwriting Agreement February 20, 2014 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 Goldman, Sachs & Co. 200 West Street New York, New...Underwriting Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionMedtronic, Inc., a Minnesota corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $250,000,000 principal amount of its Floating Rate Senior Notes due 2017 (the “2017 Floating Rate Notes”), $250,000,000 principal amount of its 0.875% Senior Notes due 2017 (the “2017 Notes”), $850,000,000 principal amount of its 3.625% Senior Notes due 2024 (the “2024 Notes”) and $650,000,000 principal amount of its 4.625% Senior Notes due 2044
FIFTH THIRD BANCORP Underwriting AgreementUnderwriting Agreement • September 17th, 2019 • Fifth Third Bancorp • State commercial banks • New York
Contract Type FiledSeptember 17th, 2019 Company Industry JurisdictionFifth Third Bancorp, an Ohio corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), 10,000,000 Depositary Shares (the “Securities”), each representing 1/1000th of a share of the Company’s Series K Preferred Stock, no par value per share and liquidation preference of $25,000 per share (each, an “Underlying Preferred Share”). The Underlying Preferred Shares, when issued, will be deposited against delivery of depositary receipts (the “Depositary Receipts”), which will evidence the Securities that are to be issued by American Stock Transfer & Trust Company, LLC, as depositary (the “Depositary”), pursuant to the terms of a deposit agreement to be entered into
FIFTH THIRD BANCORP Underwriting Agreement June 2, 2014Underwriting Agreement • June 5th, 2014 • Fifth Third Bancorp • State commercial banks • New York
Contract Type FiledJune 5th, 2014 Company Industry JurisdictionFifth Third Bancorp, an Ohio corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), 300,000 Depositary Shares (the “Securities”), each representing 1/25th of a share of the Company’s Series J Preferred Stock, no par value per share and liquidation preference of $25,000 per share (each, an “Underlying Preferred Share”). The Underlying Preferred Shares, when issued, will be deposited against delivery of depositary receipts (the “Depositary Receipts”), which will evidence the Securities that are to be issued by Wilmington Trust, National Association, as depositary (the “Depositary”), pursuant to the terms of a deposit agreement to be entered into among the Company, the Depositary, and the holders from time to time of Depositary Receipts delivered thereunder (the “Deposit Agreement”). For purposes of this Agreement, “Depositary Shares” means the
UNDERWRITING AGREEMENT MEDTRONIC, INC. Floating Rate Senior Notes due 2017 0.875% Senior Notes due 2017 3.625% Senior Notes due 2024 4.625% Senior Notes due 2044 Underwriting AgreementUnderwriting Agreement • February 27th, 2014 • Medtronic Inc • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledFebruary 27th, 2014 Company Industry Jurisdiction
Prudential Financial, Inc. UNDERWRITING AGREEMENT March 7, 2013Underwriting Agreement • March 14th, 2013 • Prudential Financial Inc • Life insurance • New York
Contract Type FiledMarch 14th, 2013 Company Industry Jurisdictionsolely to cover over-allotments. The Underwritten Securities and the Option Securities are herein referred to collectively as the “Securities.” The Securities will be issued pursuant to an Indenture dated as of June 17, 2008 (the “Base Indenture”) between the Company and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee (the “Trustee”), as supplemented by the eighth supplemental indenture, to be dated as of March 14, 2013 (the “Eighth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company and the Trustee.
Prudential Financial, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • December 4th, 2012 • Prudential Financial Inc • Life insurance • New York
Contract Type FiledDecember 4th, 2012 Company Industry JurisdictionPrudential Financial, Inc., a New Jersey corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, UBS Securities LLC and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”), $500,000,000 principal amount of its 5.75% Junior Subordinated Notes due 2052 (the “Underwritten Securities”), and, at the option of the Representatives acting on behalf of the Underwriters, up to an additional $75,000,000 aggregate principal amount of such 5.75% Junior Subordinated Notes due 2052 (the “Option Securities”), solely to cover over-allotments. The Underwritten Securities and the Option Securities are herein referred to collectively as the “Securities.” The Securities will be issued pursuant to an Indenture dated as of June 17, 2008 (the “Base Indenture”) between the Company and The Bank of New York Mellon (forme